Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease

Abstract

Inflammatory bowel disease is caused by chronic inflammation of the gastrointestinal tract and disturbed immune responses. Here the authors present examination of Cortistatin analogues that display enhanced half-life stability whilst maintaining immunomodulatory functionality.